Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Immunovant, Inc. (IMVT) Days Sales in Receivables data is not available.
| Income Statement Financials | |
-- |
|
$-210.96M |
|
-- |
|
-- |
|
$218.28M |
|
$-218.28M |
|
$7.33M |
|
$-210.95M |
|
$-210.95M |
|
$-210.96M |
|
$-210.96M |
|
$-210.96M |
|
$-210.96M |
|
$-218.28M |
|
$-218.08M |
|
123.08M |
|
123.08M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$404.33M |
|
$0.33M |
|
$1.50M |
|
$405.84M |
|
$43.30M |
|
-- |
|
$0.05M |
|
$43.34M |
|
$362.49M |
|
$362.49M |
|
$362.49M |
|
130.33M |
|
| Cash Flow Statement Financials | |
$-188.19M |
|
$-0.20M |
|
$70.89M |
|
$493.82M |
|
$376.53M |
|
$-117.28M |
|
$32.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-188.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Days Sales in Receivables |
-- |
-58.20% |
|
-58.20% |
|
-51.98% |
|
-58.20% |
|
$2.78 |
|
$-1.53 |
|
$-1.53 |
|